Newer laboratory indices for identification of metabolic dysfunction-associated steatotic liver disease in obesity
Introduction: The global incidence of metabolic dysfunction-associated steatotic liver disease (MASLD) is in the rise in the setting of obesity. Currently, hepatic steatosis is being diagnosed with imaging techniques, blood biomarkers, or liver biopsy. This study explores the newer laboratory indice...
Uloženo v:
| Hlavní autoři: | , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Wolters Kluwer Medknow Publications
2025-11-01
|
| Edice: | Journal of Family Medicine and Primary Care |
| Témata: | |
| On-line přístup: | https://journals.lww.com/10.4103/jfmpc.jfmpc_1767_24 |
| Tagy: |
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
|
